Long Term Outcome in Adolescents with Hodgkin's Lymphoma: Poor Results using Regimens Designed for Adults

References

• Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W. and Tubiana, M. (1971) "Report on the Committee on Hodgkin's Disease Staging Classification", Cancer Research, 31, 1860.
   Google Scholar
• Rosenberg, S.A., Boiron, M., DeVita, V.T., et al. (1971) "Report on the committee on Hodgkin's disease staging procedures", Cancer Research, 31, 1864.
   Google Scholar
• Lister, T.A., Crowther, D., Sutcliffe, S.B., Glatstein, E., Canellos, G.P., Young, R.C., et al. (1989) "Report of a Committee convened to discuss the evaluation and Staging of Patients with Hodgkin's disease: Cotswolds meeting", Journal of Clinical Oncology, 7(11), 1630— 1636.
   Google Scholar
• Specht, L., Gray, R.G., Clarke, M.J. and Peto, R. (1998) "Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3,888 patients. Interna-tional Hodgkin's Disease Collaborative Group", Journal of Clinical Oncology, 16(3), 830–843.
   Google Scholar
• DeVita, V.T., Jr., Serpick, A.A. and Carbone, P.P. (1970) "Combination chemotherapy in the treatment of advanced Hodg-kin's disease", Annals of Internal Medicine, 73, 881 —895.
   Google Scholar
• Hancock, B.W., Vaughan, H.G., Vaughan, H.B., Haybittle, J.L., Bennett, M.H., Maclennan, K.A., et al. (1991) "British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease-long term results", British Journal of Cancer, 63(4), 579— 582.
   Google Scholar
• McElwain, T.J., Toy, J., Smith, E., Peckham, M.J. and Austin, D.E. (1977) "A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease", British Journal of Cancer, 36, 276— 280.
   Google Scholar
• Bonadonna, G., Zucali, R., Monfardini, S., De Lena, M. and Uslenghi, C. (1975) "Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP", Cancer, 36(1), 252–259.
   Google Scholar
• Viviani, S., Bonadonna, G., Santoro, A., Bonfante, V., Zanini, M., Devizzi, L., et al. (1996) "Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results", Journal of Clinical Oncology, 14(5), 1424 — 1430.
   Google Scholar
• Canellos, G.P., Anderson, J.R., Propert, K.J., Nissen, N., Cooper, M..R., Henderson, ES., et al. (1992) "Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD", New England Journal of Medicine, 327(21), 1478–1484.
   Google Scholar
• Duggan, D.B., Petroni, G.R., Johnson, J.L., Glick, J.H., Fisher, RI., Connors, J.M., et al. (2003) "Randomised comparison of ABVD and MOPP/ABV hybrid for the treatment of Advanced Hodgkin's disease: report of an intergroup trial", Journal of Clinical Oncology, 21(4), 607–614.
   Google Scholar
• Diehl, V., Franklin, J., Pfreundschuh, M., Lathan, B., Paulus, U., Hasenclever, D., et al. (2003) "Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for ad-vanced Hodgkin's disease", New England Journal of Medicine, 348(24), 2386–2395.
   Google Scholar
• Hancock, S.L., Donaldson, S.S. and Hoppe, R.T. (1993) "Cardiac disease following treatment of Hodgkin's disease in children and adolescents", Journal of Clinical Oncology, 11(7), 1208 — 1215.
   Google Scholar
• Vaughan, H.B., Vaughan, HG., Linch, D.C. and Anderson, L. (1994) "Late mortality in young BNLI patients cured of Hodgkin's disease", Annals of Oncology, 5\(supp 2), s65— s66.
   Google Scholar
• Ng, AK., Bernardo, M.P., Weller, E., Backstrand, K.H., Silver, B., Marcus, K.C., et al. (2002) "Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger", Journal of Clinical Oncology, 20(8), 2101–2108.
   Google Scholar
• Hancock, S.L., Tucker, M.A. and Hoppe, R.T. (1993) "Factors affecting late mortality from heart disease after treatment of Hodgkin's disease", Journal of American Medical Association, 270(16), 1949–1955.
   Google Scholar
• Schellong, G. (1996) "Treatment of children and adolescents with Hodgkin's disease: the experience of the German-Austrian Paedia-tric Study Group", Baillieres Clinical Haematology, 9(3), 619–634.
   Google Scholar
• Schellong, G., Potter, R., Bramswig, J., Wagner, W., Prott, F.J., Dorffel, W., et al. (1999) "High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group", Journal of Clinical Oncology, 17(12), 3736–3744.
   Google Scholar
• Donaldson, S.S. and Link, M.P. (1997) "Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease", Journal of Clinical Oncology, 5(5), 742— 749.
   Google Scholar
• Hutchinson, R.J., Fryer, CJ., Davis, P.C., Nachman, J., Krailo, M.D., O'Brien, R.T., et al. (1998) "MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial", Journal of Clinical Oncology, 16(3), 897 — 906.
   Google Scholar
• Hunger, S.P., Link, M.P. and Donaldson, S.S. (1994) "ABVD/ MOPP and low-dose involved field radiotherapy in Pediatric Hodgkin's disease: the Stanford experience", Journal of Clinical Oncology, 12(10), 2160–2166.
   Google Scholar
• Vecchi, V., Pileri, S., Burnelli, R., Bontempi, N., Comelli, A., Testi, A.M., et al. (1993) "Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients", Cancer, 72(6), 2049–2057.
   Google Scholar
• Vecchi, V., Burnelli, R., Di Fabio, F. and Frezza, G. (1997) "Childhood Hodgkin's disease: results of the Italian multicentric study AIEOP-MH'89-CNR", Medical Paediatric Oncology, 29(5), 434.
   Google Scholar
• Vaughan-Hudson, B., on behalf of the British National Lymphoma Investigation. (1998) "The BNLI: Past and Present", Clinical Oncology, 10, 212–218.
   Google Scholar
• Clarke, CA., Glaser, S.L. and Prehn, A.W. (2001) "Age-specific survival after Hodgkin's disease in a population-based cohort (United States)", Cancer Causes Control, 12(9), 803–812.
   Google Scholar
• Weiner, M.A., Levanthal, B.G., Marcus, R., et al. (1991) "Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group Study", Journal of Clinical Oncology, 9(9), 1591 — 1598.
   Google Scholar
• British National Lymphoma Investigation. (1976) "Initial treatment of stage IIIA Hodgkin's disease. Comparison of radiotherapy with combined chemotherapy. British National Lymphoma Investiga-tion", Lancet (1976), 991–996.
   Google Scholar
• Jones, SE., Haut, A., Weick, J.K., Wilson, HE., Grozea, P., Fabian, CJ., et al. (1983) "Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the manage-ment of advanced Hodgkin's disease. A Southwest Oncology Group Study", Cancer, 51, 1339— 1347.
   Google Scholar
• Hancock, B.W., Vaughan, HG., Vaughan, H.B., Bennett, M.H., Maclennan, K.A., Haybittle, J.L., et al. (1992) "LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lympho-ma Investigation trial", Journal of Clinical Oncology, 10(8), 1252 — 1258.
   Google Scholar
• Hancock, B.W., Gregory, W.M., Cullen, M.H., Hudson, G.V., Burton, A., Selby, P., et al. (2001) "Ch1VPP alternating with PAB10E is superior to PAB10E alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lympho-ma Investigation/Central Lymphoma Group randomized controlled trial", British Journal of Cancer, 84(10), 1293 — 1300.
   Google Scholar
• Cullen, M.H., Stuart, N.S., Woodroffe, C., Murphy, A., Fletcher, J., Blackledge, G.R., et al. (1994) "Ch1VPP/PAB10E and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group", Journal of Clinical Oncology, 12(4), 779 — 787.
   Google Scholar
• Tubiana, M., Henry-Amar, M., Hayat, M., Burgers, M., Qasim, M., Somers, R., et al. (1984) "The EORTC treatment of early stage Hodgkin's disease: the role of radiotherapy", International Journal of Radiation Oncology Biology Physics, 10, 197.
   Google Scholar
• Swerdlow, A.J., Douglas, A.J., Hudson, G.V., Hudson, B.V., Bennett, M.H., Maclennan, K.A. (1992) "Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation", British Medical Journal, 301, 1137–1143.
   Google Scholar
• Frezzato, M., Castaman, G. and Rodeghiero, F. (1993) "Fulminant sepsis in adults splenectomized for Hodgkin's disease", Haemato-logica, 78(6 suppl 2), 73–7.
   Google Scholar
• Donaldson, S.S. and Hancock, S.L. (1996) "Second cancers after Hodgkin's disease in childhood", New England Journal of Medicine, 334(12), 792–794.
   Google Scholar
• Yung, L. and Linch, D.C. (2003) "Seminar in Hodgkin's Lymphoma", Lancet, 361, 943–951.
   Google Scholar
• Landman-Parker, J., Pacquement, H., Leblanc, T., Habrand, J.L., Terrier-Lacombe, Mi., Bertrand, Y., et al. (2000) "Localised childhood Hodgkin's disease: response-adapted chemotherapy with etoposide, bleomycin, vinblastine, and prednisone before low-dose radiation therapy-results of the French Society of Pediatric Oncology Study MDH90", Journal of Clinical Oncology, 18(7), 1500 — 1507.
   Google Scholar
• Connors, J.M., Klimo, P., Adams, G., Burns, B.F., Cooper, I., Meyer, R.M., et al. (1997) "Treatment of advanced Hodgkin's disease with chemotherapy-comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group", Journal of Clinical Oncology, 15(4), 1638–1645.
   Google Scholar
• Bhatia, S., Robison, L.L., Oberlin, 0., Greenberg, M., Bunin, G., Fossati-Bellani, F., et al. (1996) "Breast cancer and other second neoplasms after childhood Hodgkin's disease", New England Journal of Medicine, 334(12), 745–751.
   Google Scholar
• Cutuli, B., Dhermain, F., Borel, C., de Larocheforcliere, A., Graic, Y., de Lafontan, B., et al. (1997) "Breast cancer in patients treated for Hodgkin's disease: clinical and pathological analysis of 76 cases in 63 patients", European Journal of Cancer, 33(14), 2315–2320.
   Google Scholar
• Metayer, C., Lynch, C.F., Clarke, E.A., Glimelius, B., Storm, H., Pukkala, E., et al. (2000) "Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence", Journal of Clinical Oncology, 18(12), 2435–2443.
   Google Scholar
• Raemaekers, J., Kluin-Nelemans, H., Teodorovic, I., Meerwaldt, C., Noordijk, E., Thomas, J., etal. (2002) "The achievements of the EORTC Lymphoma Group. European Organisation for Research and Treatment of Cancer", European Journal of Cancer, 38\(suppl 4), S107 —S113.
   Google Scholar
• Levi, F., Lucchini, F., Negri, E., Boyle, P. and La Vecchia, C. (2002) "Trends in mortality from Hodgkin's disease in western and eastern Europe", British Journal of Cancer, 87, 291— 293.
   Google Scholar